Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2R44DA050218-02 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
| University of California, Los Angeles | OTHER |
| Massachusetts General Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to learn if/how an AI chatbot can support patients who in recovery for substance use, specifically those who are receiving medication for opioid use disorder.
Can the chatbot help lower drug use? Can the chatbot help improve clinical appointment adherence? Can the chatbot help patients build self-efficacy in leading their own recovery journey? Will the chatbot help reduce workload burden for primary care teams? Can the chatbot serve as a safe, useful and engaging tool to support patients?
Researchers will investigate the effects of using a chatbot to support follow-up care for patients in opioid use recovery.
Participants will:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Chatbot | Experimental | Participants will receive access to a chatbot for 12 weeks that can be used from a mobile device to support follow-up care and recovery needs. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| chatbot | Other | Participants will:
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in SUD severity | Addiction Severity Index (ASI) Drugs composite score; Scored 0-7 with higher scores indicating increasing severity | 12 weeks |
| Change in psychological health (Anxiety) | General Anxiety Disorder-7 (GAD-7); scored 0-21 with higher scores indicating increasing anxiety | 12 weeks |
| Change in psychological health (Depression) | Patient Health Questionnaire-8 (PHQ-8); scored 0-24 with higher scores indicating more severe depression | 12 weeks |
| Change in self-efficacy for managing chronic conditions (Emotions) | PROMIS Short Form 8a (Managing Emotions); scored from 8-40 with higher scores indicating higher confidence managing emotions | 12 weeks |
| Change in self-efficacy for managing chronic conditions (Social Interactions) | PROMIS Short Form 8a (Social Interactions); scored from 8-40 with higher scores indicating higher confidence with managing social interactions | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in quality of life | World Health Organization Quality of Life (WHOQoL-BREF) Assessment; higher scores indicate higher quality of life | 12 weeks |
| Change in social needs | Accountable Health Communities Health-Related Social Needs (AHC HRSN) screening; higher scores indicate higher unmet social needs |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Y. Xian Ho, PhD | Dimagi Inc. | Principal Investigator |
| Jonathan Jackson, MEng | Dimagi Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States |
This study will include sensitive data from a small sample of patients with experience with substance use therefore data will be reported in aggregate and only qualitative data collected from participants may be reported individually and anonymously.
Not provided
Not provided
Not provided
Not provided
Not provided
Pre-Post Intervention
Not provided
Not provided
Not provided
Not provided
|
|
| 12 weeks |
| Chatbot usability | Chatbot Usability Questionnaire (CUQ); scored 0-100 with higher scores indicating higher usability | End of 12 week intervention |
| User Satisfaction | Net Promoter Score (NPS); scored -100 to 100 with higher scores indicating higher user satisfaction | End of 12 week intervention |